EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out?

• Alejandra Castanon,
• Rebecca Sloan,
• Luisamanda Selle Arocha,
• Sreeram V Ramagopalan

Affiliations

Alejandra Castanon

Lane Clark & Peacock LLP, London, W1U 9DQ, UK

Rebecca Sloan

Lane Clark & Peacock LLP, London, W1U 9DQ, UK

Luisamanda Selle Arocha

Lane Clark & Peacock LLP, London, W1U 9DQ, UK

Sreeram V Ramagopalan

Lane Clark & Peacock LLP, London, W1U 9DQ, UK; Centre for Pharmaceutical Medicine Research, King’s College London, London, SE1 9NH, UK